The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Marketwire

ProMetic Announces Details of the Conference Call - Webcast for Its Third Quarter 2010 Financial Results

Thursday, November 11, 2010

ProMetic Announces Details of the Conference Call - Webcast for Its Third Quarter 2010 Financial Results06:00 EST Thursday, November 11, 2010MONTREAL, QUEBEC--(Marketwire - Nov. 11, 2010) - ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic") today announces that the Company will be holding a conference call / webcast on Tuesday, November 16, 2010, at 10:00 (EST) further to the release of its Third Quarter 2010 financial results on Monday, November 15, 2010, after close of market.The numbers to access the conference call are (416) 620-5690 (international) and 1 (888) 633-8497 (North America toll free). A live audio webcast of the conference call will be available through ProMetic's website at http://www.prometic.com/en/news-events/events.php.An audio replay of the call will be available for a period of seven days as of Tuesday, November 16, 2010, at 13:00 (EST). The numbers to access the audio replay are (416) 626-4100 (international) and 1 (800) 558-5253 (North America toll free) using access code 21484723. The replay of the web cast may be downloaded directly from ProMetic's web site.About ProMetic Life Sciences Inc. ProMetic Life Sciences Inc. ("ProMetic") (www.prometic.com) is a biopharmaceutical company specialized in the research, development, manufacture and marketing of a variety of commercial applications derived from its proprietary Mimetic Ligand™ technology. This technology is used in large-scale purification of biologics and the elimination of pathogens. ProMetic is also active in therapeutic drug development with the mission to bring to market effective, innovative, lower cost, less toxic products for the treatment of hematology and cancer. Its drug discovery platform is focused on replacing complex, expensive proteins with synthetic "drug-like" protein mimetics. Headquartered in Montréal (Canada), ProMetic has R&D facilities in the UK, the US and Canada, manufacturing facilities in the UK and business development activities in the US, Europe, Asia and in the Middle-East.FOR FURTHER INFORMATION PLEASE CONTACT: ProMetic Life Sciences Inc.Company inquiries:Pierre Laurin, President and CEO514-341-2115p.laurin@prometic.comORAnne LeducProMetic Life Sciences Inc.Manager, Investor Relations & Communications514-341-2115a.leduc@prometic.com